HCA Healthcare (NYSE:HCA – Get Free Report) had its target price lowered by stock analysts at Stephens from $300.00 to $280.00 in a research note issued to investors on Wednesday, Benzinga reports. The firm currently has an “overweight” rating on the stock. Stephens’ price objective points to a potential upside of 26.23% from the stock’s previous close.
A number of other brokerages have also issued reports on HCA. Credit Suisse Group boosted their target price on HCA Healthcare from $311.00 to $316.00 and gave the company an “outperform” rating in a research report on Friday, July 28th. StockNews.com upgraded shares of HCA Healthcare from a “buy” rating to a “strong-buy” rating in a research note on Tuesday. Barclays boosted their price target on shares of HCA Healthcare from $275.00 to $300.00 in a research note on Wednesday, June 28th. Sanford C. Bernstein dropped their price target on shares of HCA Healthcare from $345.00 to $294.00 in a research note on Tuesday, October 10th. Finally, VNET Group restated a “maintains” rating on shares of HCA Healthcare in a research note on Wednesday, June 28th. Two research analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $298.09.
HCA Healthcare Stock Down 1.6 %
HCA Healthcare (NYSE:HCA – Get Free Report) last posted its earnings results on Tuesday, October 24th. The company reported $3.91 earnings per share for the quarter, missing the consensus estimate of $3.97 by ($0.06). The company had revenue of $16.21 billion during the quarter, compared to analyst estimates of $15.77 billion. HCA Healthcare had a net margin of 9.05% and a return on equity of 2,040.32%. On average, equities research analysts predict that HCA Healthcare will post 18.39 earnings per share for the current year.
Insider Activity
In other news, SVP Kathleen M. Whalen sold 2,916 shares of the company’s stock in a transaction dated Thursday, August 3rd. The shares were sold at an average price of $270.00, for a total value of $787,320.00. Following the completion of the sale, the senior vice president now directly owns 10,250 shares of the company’s stock, valued at $2,767,500. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. In related news, SVP Kathleen M. Whalen sold 2,916 shares of the stock in a transaction dated Thursday, August 3rd. The shares were sold at an average price of $270.00, for a total transaction of $787,320.00. Following the completion of the transaction, the senior vice president now directly owns 10,250 shares of the company’s stock, valued at $2,767,500. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, SVP Kathryn A. Torres sold 5,204 shares of the stock in a transaction dated Monday, August 14th. The stock was sold at an average price of $269.12, for a total transaction of $1,400,500.48. Following the transaction, the senior vice president now directly owns 19,760 shares of the company’s stock, valued at $5,317,811.20. The disclosure for this sale can be found here. Over the last three months, insiders sold 9,620 shares of company stock valued at $2,592,820. Insiders own 1.60% of the company’s stock.
Institutional Inflows and Outflows
Hedge funds have recently added to or reduced their stakes in the stock. Northwest Investment Counselors LLC increased its holdings in HCA Healthcare by 92.9% in the third quarter. Northwest Investment Counselors LLC now owns 108 shares of the company’s stock valued at $27,000 after buying an additional 52 shares in the last quarter. BluePath Capital Management LLC acquired a new stake in shares of HCA Healthcare in the third quarter valued at approximately $27,000. James Investment Research Inc. acquired a new stake in shares of HCA Healthcare in the first quarter valued at approximately $31,000. FinTrust Capital Advisors LLC acquired a new stake in shares of HCA Healthcare in the third quarter valued at approximately $32,000. Finally, Concord Wealth Partners grew its position in shares of HCA Healthcare by 54.1% in the first quarter. Concord Wealth Partners now owns 151 shares of the company’s stock valued at $40,000 after purchasing an additional 53 shares during the last quarter. 62.73% of the stock is owned by hedge funds and other institutional investors.
About HCA Healthcare
HCA Healthcare, Inc, through its subsidiaries, provides health care services in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.
Featured Articles
- Five stocks we like better than HCA Healthcare
- What is the Euro STOXX 50 Index?
- Watch for bears as S&P 500 slices 200-day line
- What Does a Stock Split Mean?
- Reasons UPS is a strong sell: Reasons to buy it when it bottoms
- How to Invest in Marijuana Stocks
- 3 hot mid-caps set to report Q3 earnings
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
